CSI Market
Sign In | Register

Nuvalent Inc (NUVL) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access NUVL quarterly Cash Flow →
This cash flow overview for Nuvalent Inc spans from Dec 31 2021 to Dec 31 2025, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-425.38
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation86.50
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Increase Decrease Value of Warrants-
Loss On Settlement Of Accounts Payable55.22
Gain Loss Related To Litigation Settlement-
Interest On Forward Purchase Contract-
Stock And Options Issued For Services-
Amortization Of Cash Conversion Feature And Warrants On Convertible Debentures-
Subsidiary Or Equity Method Investee Minority Interest In Income Of Subsidiary-
Interest Earned On Due From Receivables-
Amortization Of Original Issue Discount On Notes Payable To Directors-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable24.60
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities11.46
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-6.34
Other Working Capital-10.51
Other Noncash Income (Expense)0.35
Other net0.00
Payments for (Proceeds from) Other Operating Activities-11.11
Discontinued operations0.00
Net Cash flow from Operating Activities-275.21
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities933.69
Payments to Acquire Marketable Securities-1,057.77
Real Estate Investments0.00
Costs Incurred In Acquisition Of Assets-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-124.08
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock515.34
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Convertible Notes Payable-
Fees Paid for Convertible Notes Payable-
Proceeds Capital Contribution-
Proceeds From Stock Subscription Receivable-
Business Combination Acquisition Related Costs-
Stock Issued-
Net Loss On Investment In Lifemed Id Inc-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities515.34
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-275.21
Total Cash Flow116.05
4 historic quarters locked

Sign in to unlock the full Nuvalent Inc cash flow history.

Sign In Create Free Account

About Nuvalent Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: nuvl-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-073317

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License